Financial Statements Statements of Cash Flows for the year ended 31 December 2023 Group Company Note 2023 RM’000 2022 RM’000 2023 RM’000 2022 RM’000 Cash flows from operating activities Profit before tax 4,049,301 2,217,091 1,374,014 282,125 Adjustments for: Dividend income 25 (454) (63) (620,995) (340,436) Finance income 27 (102,764) (113,383) (8,238) (13,968) Finance costs 27 941,319 657,413 10 317 Depreciation and impairment of property, plant and equipment 3 1,072,505 1,374,475 127 233 Depreciation and impairment of right-of-use assets 4 390,645 357,893 999 1,000 Amortisation and impairment of intangible assets 6 47,720 58,452 – – Impairment loss made: − Goodwill 28 – 150,066 – – − Trade and other receivables 28 99,226 44,686 – 8,567 Write-off: − Property, plant and equipment 28 1,851 1,087 – – − Trade and other receivables 28 13,843 10,048 – – − Inventories 28 6,679 4,296 – – Gain on disposal of property, plant and equipment 28 (10,691) (11,864) – – Gain on disposal of subsidiaries 28 (991,480) – (827,545) – Gain on disposal of interests in associates 28 (3,723) – – – Gain on disposal of assets (1,946) – – – Change in fair value of investment properties 28 (9,299) (23,750) – – Share of profits of associates (net of tax) (24,784) (36,836) – – Share of profits of joint ventures (net of tax) (1,466) (2,035) – – Equity-settled share-based payments 7,714 3,319 3,227 1,353 Net monetary gain arising from hyperinflationary economy (703,941) (462,512) – – Operating profit/(loss) before changes in working capital 4,780,255 4,228,383 (78,401) (60,809) Changes in working capital: Development properties (2,325) (2,609) – – Inventories (193,243) (108,513) – – Trade and other receivables (550,151) (579,931) (49,546) 77,506 Trade and other payables 378,878 746,445 (31,528) (799,733) Cash generated from/(used in) operations 4,413,414 4,283,775 (159,475) (783,036) Tax paid (653,980) (616,132) (3,816) (3,001) Net cash from/(used in) operating activities 3,759,434 3,667,643 (163,291) (786,037) The notes on pages 148 to 248 are an integral part of these financial statements. IHH Healthcare Berhad 146
RkJQdWJsaXNoZXIy NDgzMzc=